Home/Filings/4/0001181431-05-010391
4//SEC Filing

RENOVIS INC 4

Accession 0001181431-05-010391

CIK 0001118361operating

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 1:52 PM ET

Size

8.5 KB

Accession

0001181431-05-010391

Insider Transaction Report

Form 4
Period: 2005-02-09
KELLY MICHAEL GERALD
VP, Drug Discovery
Transactions
  • Award

    Incentive Stock Option (Right to buy)

    2005-02-09+60,00060,000 total
    Exercise: $11.70From: 2005-02-09Exp: 2015-02-09Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]Subject to normal Company vesting practices
  • [F2]Not applicable

Issuer

RENOVIS INC

CIK 0001118361

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001118361

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 1:52 PM ET
Size
8.5 KB